BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32516598)

  • 21. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
    Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
    Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EXO1 protects BRCA1-deficient cells against toxic DNA lesions.
    van de Kooij B; Schreuder A; Pavani R; Garzero V; Uruci S; Wendel TJ; van Hoeck A; San Martin Alonso M; Everts M; Koerse D; Callen E; Boom J; Mei H; Cuppen E; Luijsterburg MS; van Vugt MATM; Nussenzweig A; van Attikum H; Noordermeer SM
    Mol Cell; 2024 Feb; 84(4):659-674.e7. PubMed ID: 38266640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APE2: catalytic function and synthetic lethality draw attention as a cancer therapy target.
    McMahon A; Zhao J; Yan S
    NAR Cancer; 2023 Mar; 5(1):zcad006. PubMed ID: 36755963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
    Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
    Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.
    Tutt A; Ashworth A
    Trends Mol Med; 2002 Dec; 8(12):571-6. PubMed ID: 12470990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.
    Fridlich R; Annamalai D; Roy R; Bernheim G; Powell SN
    DNA Repair (Amst); 2015 Jun; 30():11-20. PubMed ID: 25836596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance.
    Kumar S; Talluri S; Pal J; Yuan X; Lu R; Nanjappa P; Samur MK; Munshi NC; Shammas MA
    Blood Cancer J; 2018 Sep; 8(10):92. PubMed ID: 30301882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-processing nucleases and phosphodiesterases: An elite supporting cast for the non-homologous end joining pathway of DNA double-strand break repair.
    Menon V; Povirk LF
    DNA Repair (Amst); 2016 Jul; 43():57-68. PubMed ID: 27262532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APE2 promotes DNA damage response pathway from a single-strand break.
    Lin Y; Bai L; Cupello S; Hossain MA; Deem B; McLeod M; Raj J; Yan S
    Nucleic Acids Res; 2018 Mar; 46(5):2479-2494. PubMed ID: 29361157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
    Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apurinic/apyrimidinic endonuclease 2 regulates the expansion of germinal centers by protecting against activation-induced cytidine deaminase-independent DNA damage in B cells.
    Guikema JE; Linehan EK; Esa N; Tsuchimoto D; Nakabeppu Y; Woodland RT; Schrader CE
    J Immunol; 2014 Jul; 193(2):931-9. PubMed ID: 24935922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination.
    Guikema JE; Linehan EK; Tsuchimoto D; Nakabeppu Y; Strauss PR; Stavnezer J; Schrader CE
    J Exp Med; 2007 Nov; 204(12):3017-26. PubMed ID: 18025127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.
    Clark CC; Weitzel JN; O'Connor TR
    Mol Cancer Ther; 2012 Sep; 11(9):1948-58. PubMed ID: 22778154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
    Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
    Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of the major abasic endonuclease (APE1) in cell viability and genotoxin resistance.
    McNeill DR; Whitaker AM; Stark WJ; Illuzzi JL; McKinnon PJ; Freudenthal BD; Wilson DM
    Mutagenesis; 2020 Feb; 35(1):27-38. PubMed ID: 31816044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks.
    De la Torre C; Pincheira J; López-Sáez JF
    Histol Histopathol; 2003 Jan; 18(1):225-43. PubMed ID: 12507302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
    Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
    Zatreanu D; Robinson HMR; Alkhatib O; Boursier M; Finch H; Geo L; Grande D; Grinkevich V; Heald RA; Langdon S; Majithiya J; McWhirter C; Martin NMB; Moore S; Neves J; Rajendra E; Ranzani M; Schaedler T; Stockley M; Wiggins K; Brough R; Sridhar S; Gulati A; Shao N; Badder LM; Novo D; Knight EG; Marlow R; Haider S; Callen E; Hewitt G; Schimmel J; Prevo R; Alli C; Ferdinand A; Bell C; Blencowe P; Bot C; Calder M; Charles M; Curry J; Ekwuru T; Ewings K; Krajewski W; MacDonald E; McCarron H; Pang L; Pedder C; Rigoreau L; Swarbrick M; Wheatley E; Willis S; Wong AC; Nussenzweig A; Tijsterman M; Tutt A; Boulton SJ; Higgins GS; Pettitt SJ; Smith GCM; Lord CJ
    Nat Commun; 2021 Jun; 12(1):3636. PubMed ID: 34140467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA gene structure and function in tumor suppression: a repair-centric perspective.
    Murphy CG; Moynahan ME
    Cancer J; 2010; 16(1):39-47. PubMed ID: 20164689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
    Liu C; Pouliot JJ; Nash HA
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14970-5. PubMed ID: 12397185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.